Preparative immunotherapy with anti-OX40 and anti-CTLA4 improves the response to chemotherapy

David J Friedman1, Kristina Young2, Jason R Baird1, Benjamin Cottam1, Talicia Savage1, Pippa Newell3,1, Melissa Kasiewicz1, William Redmond1, Brendan Curti1, Todd Crocenzi1, Michael J Gough1, Marka Crittenden3,1
1Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, USA
2Department of Radiation Medicine, Oregon Health & Science University, Portland, USA
3The Oregon Clinic, Portland, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo